Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date Location
Omeros Accused on Eve of IPO, Seattle Genetics Trial Fails, How Much Biotechies Really Earn, & More Seattle-Area Life Sciences News Luke Timmerman 10/08/09 Seattle
Seattle Genetics Shares Drop on Halted Lymphoma Trial Luke Timmerman 10/05/09 Seattle
Genzyme’s Mozobil Gets European Approval Ryan McBride 08/05/09 Boston
Fate Therapeutics Starts First Clinical Trial of Drug to Boost Stem Cell Transplants Ryan McBride 05/27/09 San Diego
Riding a Cancer Diagnostics Wave, Genoptix Sees Boom Continuing in 2009 Luke Timmerman 04/01/09 San Diego
Cell Therapeutics Reports Severe Cardiac Events in Drug Trial Luke Timmerman 03/16/09 Seattle
Seattle Genetics Gets Orphan Drug Status Luke Timmerman 01/26/09 Seattle
Genzyme Wins FDA Approval of Mozobil Luke Timmerman 12/15/08 Boston
Blood News: A Quick Rundown of Headlines From the American Society of Hematology Luke Timmerman 12/09/08 National
Gloucester Drug Shrinks Tumors in Lymphoma Study Luke Timmerman 12/08/08 Boston
Seattle Genetics “Empowered Antibody” Shines at Blood Disease Meeting Luke Timmerman 12/06/08 Seattle
Zevalin Gets 6-Month FDA Review Luke Timmerman 12/01/08 Seattle
Cell Therapeutics, Spectrum Form Joint Venture Gregory T. Huang 11/26/08 Seattle
Cell Therapeutics Lymphoma Drug Wipes Out Tumors in Pivotal Trial Luke Timmerman 11/11/08 Seattle
Cell Therapeutics, Still Fighting, Gets Zevalin Data Published In Cancer Journal Luke Timmerman 10/16/08 Seattle
Cell Therapeutics To File for FDA Approval of Zevalin In First-Line Lymphoma Luke Timmerman 09/22/08 Seattle
Biogen Idec Isn’t Sweating Possible Sale of Genentech to Roche Luke Timmerman 07/22/08 Boston
Page 1 of 1
    
Xconomy network map Seattle Boston San Diego
national life-sciences startups

Most Popular Stories

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2009, Xconomy, Inc. XCONOMY is a registered service mark of Xconomy, Inc. All rights reserved.
Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.